Success Story of Targeted Therapy in Chronic Myeloid Leukemia: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2008

PURPOSE: Chronic myeloid leukemia (CML) management changed dramatically with the development of imatinib mesylate (IM), the first tyrosine kinase inhibitor targeting the BCR-ABL1 oncoprotein. In Sweden, the drug was approved in November 2001. We report relative survival (RS) of patients with CML dia...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Björkholm, Magnus, Ohm, Lotta, Eloranta, Sandra, Derolf, Åsa, Hultcrantz, Malin, Sjöberg, Jan, Andersson, Therese, Höglund, Martin, Richter, Johan, Landgren, Ola, Kristinsson, Sigurdur Y., Dickman, Paul W.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2011
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3138632/
https://ncbi.nlm.nih.gov/pubmed/21576640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.34.7146
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados